2.2.0.25truefalse40101 - Disclosure - Organization and Summary of Significant Accounting Policies (Narrative) (Details)truefalseShare data in Millions, except Per Share data, unless otherwise specifiedfalse1falsefalseUSDfalsefalse12/1/2010 - 12/31/2010
USD ($)
$Duration_12_1_2010_To_12_31_2010http://www.sec.gov/CIK0000882095duration2010-12-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000882095duration2010-01-01T00:00:002010-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse1/1/2009 - 12/31/2009
USD ($)
USD ($) / shares
$Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000882095duration2009-01-01T00:00:002009-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDfalsefalse1/1/2008 - 12/31/2008
USD ($)
USD ($) / shares
$Duration_1_1_2008_To_12_31_2008http://www.sec.gov/CIK0000882095duration2008-01-01T00:00:002008-12-31T00:00:00Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit1Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$5falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : Warrants Expiring in 2011 [Member]
12/31/2010
USD ($) / shares
$As_Of_12_31_2010231http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseWarrants Expiring in 2011 [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_WarrantsExpiringInTwoThousandElevenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$6falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : Warrants Expiring in 2013 [Member]
12/31/2010
USD ($) / shares
$As_Of_12_31_2010234http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseWarrants Expiring in 2013 [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_WarrantsExpiringInTwoThousandThirteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : Warrants Expiring in 2014 [Member]
12/31/2010
USD ($) / shares
$As_Of_12_31_2010232http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseWarrants Expiring in 2014 [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_WarrantsExpiringInTwoThousandFourteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$8falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : Warrants Expiring in 2016 [Member]
12/31/2010
USD ($) / shares
$As_Of_12_31_2010233http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseWarrants Expiring in 2016 [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_WarrantsExpiringInTwoThousandSixteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit14Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$9falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2011 Convertible Senior Notes [Member]
12/31/2010
USD ($)
$As_Of_12_31_201023http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalse2011 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandElevenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2011 Convertible Senior Notes [Member]
4/30/2006
USD ($)
$As_Of_4_30_2006http://www.sec.gov/CIK0000882095instant2006-04-30T00:00:000001-01-01T00:00:00falsefalse2011 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandElevenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2013 Convertible Senior Notes [Member]
12/31/2010
USD ($)
$As_Of_12_31_201024http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalse2013 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandThirteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2013 Convertible Senior Notes [Member]
4/30/2006
USD ($)
$As_Of_4_30_20062http://www.sec.gov/CIK0000882095instant2006-04-30T00:00:000001-01-01T00:00:00falsefalse2013 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandThirteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$13falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2014 Convertible Senior Notes [Member]
12/31/2010
USD ($)
$As_Of_12_31_20104http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalse2014 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandFourteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2014 Convertible Senior Notes [Member]
7/31/2010
USD ($)
$As_Of_7_31_2010http://www.sec.gov/CIK0000882095instant2010-07-31T00:00:000001-01-01T00:00:00falsefalse2014 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandFourteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$15falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2016 Convertible Senior Notes [Member]
12/31/2010
USD ($)
$As_Of_12_31_201026http://www.sec.gov/CIK0000882095instant2010-12-31T00:00:000001-01-01T00:00:00falsefalse2016 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandSixteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$16falsefalseUSDtruefalse{us-gaap_LongtermDebtTypeAxis} : 2016 Convertible Senior Notes [Member]
7/31/2010
USD ($)
$As_Of_7_31_20102http://www.sec.gov/CIK0000882095instant2010-07-31T00:00:000001-01-01T00:00:00falsefalse2016 Convertible Senior Notes [Member]us-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldigild_ConvertibleSeniorNotesDueInTwoThousandSixteenMemberus-gaap_LongtermDebtTypeAxisexplicitMemberUnit12Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$2false0us-gaap_AdvertisingExpenseus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse116500000116500000falsetruefalsefalsefalse3truefalsefalse108100000108100000falsetruefalsefalsefalse4truefalsefalse9620000096200000falsetruefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryAmount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-7
falsefalse3false0us-gaap_DebtInstrumentConvertibleConversionPriceus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9truefalsefalse38.7538.75falsefalsefalsetruefalse10truefalsefalse38.7538.75falsefalsefalsetruefalse11truefalsefalse38.1038.10falsefalsefalsetruefalse12truefalsefalse38.1038.10falsefalsefalsetruefalse13truefalsefalse45.0845.08falsefalsefalsetruefalse14truefalsefalse45.0845.08falsefalsefalsetruefalse15truefalsefalse45.4145.41falsefalsefalsetruefalse16truefalsefalse45.4145.41falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe price per share of the conversion feature embedded in the debt instrument.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number APB14-1
-Paragraph 32
-Subparagraph b
falsefalse4false0us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5truefalsefalse50.8050.80falsetruefalsetruefalse6truefalsefalse53.9053.90falsetruefalsetruefalse7truefalsefalse56.7656.76falsetruefalsetruefalse8truefalsefalse60.1060.10falsetruefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseEPSus-types:perUnitItemTypedecimalThe exercise price of each class of warrants or rights outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph i
-Subparagraph 4
-Article 4
falsetrue5false0us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse2250000022.5falsefalsefalsefalsefalse3truefalsefalse1740000017.4falsefalsefalsefalsefalse4truefalsefalse1140000011.4falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseSharesxbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 13, 14
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 171
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph c
falsefalse6false0gild_PercentageOfFairValueOfSecuritiesSoldToUsCollateralizedByUsGovernmentSecuritiesgildfalsenainstantPercentage Of Fair Value Of Securities Sold To Us Collateralized By US Government Securitiesfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truetruefalse1.021.02falsefalsefalsefalsefalse2truetruefalse1.021.02falsefalsefalsefalsefalse3falsetruefalse00falsefalsefalsefalsefalse4falsetruefalse00falsefalsefalsefalsefalse5falsetruefalse00falsefalsefalsetruefalse6falsetruefalse00falsefalsefalsetruefalse7falsetruefalse00falsefalsefalsetruefalse8falsetruefalse00falsefalsefalsetruefalse9falsetruefalse00falsefalsefalsetruefalse10falsetruefalse00falsefalsefalsetruefalse11falsetruefalse00falsefalsefalsetruefalse12falsetruefalse00falsefalsefalsetruefalse13falsetruefalse00falsefalsefalsetruefalse14falsetruefalse00falsefalsefalsetruefalse15falsetruefalse00falsefalsefalsetruefalse16falsetruefalse00falsefalsefalsetruefalseOtherus-types:percentItemTypepurePercentage Of Fair Value Of Securities Sold To Us Collateralized By US Government SecuritiesNo authoritative reference available.falsefalse7false0gild_PurchaseCostOfRoyaltiesInterestgildfalsedebitinstantPurchase Cost Of Royalties Interestfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse525000000525000000falsefalsefalsefalsefalse2truefalsefalse525000000525000000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryPurchase Cost Of Royalties InterestNo authoritative reference available.falsefalse8false0gild_PercentageShareCostOfRoyaltyInterestgildfalsenadurationPercentage Share Cost Of Royalty Interestfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsetruefalse00falsefalsefalsefalsefalse2truetruefalse0.650.65falsefalsefalsefalsefalse3falsetruefalse00falsefalsefalsefalsefalse4falsetruefalse00falsefalsefalsefalsefalse5falsetruefalse00falsefalsefalsetruefalse6falsetruefalse00falsefalsefalsetruefalse7falsetruefalse00falsefalsefalsetruefalse8falsetruefalse00falsefalsefalsetruefalse9falsetruefalse00falsefalsefalsetruefalse10falsetruefalse00falsefalsefalsetruefalse11falsetruefalse00falsefalsefalsetruefalse12falsetruefalse00falsefalsefalsetruefalse13falsetruefalse00falsefalsefalsetruefalse14falsetruefalse00falsefalsefalsetruefalse15falsetruefalse00falsefalsefalsetruefalse16falsetruefalse00falsefalsefalsetruefalseOtherus-types:percentItemTypepurePercentage Share Cost Of Royalty InterestNo authoritative reference available.falsefalse9false0gild_PercentageShareCostOfRoyaltyInterestByRoyaltyPharmagildfalsenadurationPercentage Share Cost Of Royalty Interest By Royalty Pharmafalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsetruefalse00falsefalsefalsefalsefalse2truetruefalse0.350.35falsefalsefalsefalsefalse3falsetruefalse00falsefalsefalsefalsefalse4falsetruefalse00falsefalsefalsefalsefalse5falsetruefalse00falsefalsefalsetruefalse6falsetruefalse00falsefalsefalsetruefalse7falsetruefalse00falsefalsefalsetruefalse8falsetruefalse00falsefalsefalsetruefalse9falsetruefalse00falsefalsefalsetruefalse10falsetruefalse00falsefalsefalsetruefalse11falsetruefalse00falsefalsefalsetruefalse12falsetruefalse00falsefalsefalsetruefalse13falsetruefalse00falsefalsefalsetruefalse14falsetruefalse00falsefalsefalsetruefalse15falsetruefalse00falsefalsefalsetruefalse16falsetruefalse00falsefalsefalsetruefalseOtherus-types:percentItemTypepurePercentage Share Cost Of Royalty Interest By Royalty PharmaNo authoritative reference available.falsefalse10false0us-gaap_PrepaidRoyaltiesus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse341300000341300000falsefalsefalsefalsefalse2truefalsefalse341300000341300000falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of amounts paid for royalties in advance of when the expense should be recognized, which will occur within one year or in the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 3
-Section A
-Paragraph 4
falsefalse11false0gild_UnamortizedPrepaidRoyaltyAssetgildfalsedebitinstantUnamortized Prepaid Royalty Assetfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse219500000219500000falsefalsefalsefalsefalse2truefalsefalse219500000219500000falsefalsefalsefalsefalse3truefalsefalse245000000245000000falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryUnamortized Prepaid Royalty AssetNo authoritative reference available.falsefalse12false0us-gaap_CostOfGoodsSoldAmortizationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse2550000025500000falsefalsefalsefalsefalse3truefalsefalse2990000029900000falsefalsefalsefalsefalse4truefalsefalse3180000031800000falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of expense recognized in the current period that reflects the allocation of the costs of intangible assets over the expected benefit period of such assets. This element applies only to intangible assets used in the production of goods.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 95
-Paragraph 28
falsefalse13false0us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomersus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse2250000022500000falsefalsefalsefalsefalse2truefalsefalse2250000022500000falsefalsefalsefalsefalse3truefalsefalse2520000025200000falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryUnamortized costs incurred for development of computer software, which is to be sold, leased or otherwise marketed, after establishing technological feasibility through to the general release of the software products. Excludes capitalized costs of developing software for internal use.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 17
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 86
-Paragraph 2, 5, 6, 11
falsefalse14false0us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2truefalsefalse37000003700000falsefalsefalsefalsefalse3truefalsefalse1640000016400000falsefalsefalsefalsefalse4truefalsefalse3650000036500000falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryChange in the balance sheet adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity for the period being reported, net of tax. If an entity's functional currency is a foreign currency, translation adjustments result from the process of translating that entity's financial statements into the reporting currency. Includes gain (loss) on foreign currency forward exchange contracts. Includes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements. Includes the gain or loss on a derivative instrument or nonderivative financial instrument that may give rise to a foreign currency transaction gain or loss under FAS 52 and that have been designated and have qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 52
-Paragraph 13, 20, 31
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 45
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17
falsefalse15false0us-gaap_ConvertibleNotesPayableus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse34800000003480000000falsefalsefalsefalsefalse2truefalsefalse34800000003480000000falsefalsefalsefalsefalse3truefalsefalse11600000001160000000falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryIncluding the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 16
-Article 9
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 22
-Article 5
falsefalse16false0us-gaap_DebtInstrumentFairValueus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse39700000003970000000falsefalsefalsefalsefalse2truefalsefalse39700000003970000000falsefalsefalsefalsefalse3truefalsefalse15800000001580000000falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryEstimated fair value of the debt instrument at the balance-sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
falsefalse17false0gild_MinimumRangeOfExciseTaxgildfalsedebitdurationMinimum Range Of Excise Taxfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse3000000030000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryMinimum Range Of Excise TaxNo authoritative reference available.falsefalse18false0gild_MaximumRangeOfExciseTaxgildfalsedebitdurationMaximum Range Of Excise Taxfalsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse5000000050000000falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryMaximum Range Of Excise TaxNo authoritative reference available.falsefalse19false0us-gaap_UseOfEstimatesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<div class="MetaData">
<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">The preparation of these Consolidated Financial Statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, intangible assets, allowance for doubtful accounts, prepaid royalties, clinical trial accruals, our tax provision and stock-based compensation. We base our estimates on historical experience and on various other market specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates. </font></p></div>The preparation of these Consolidated Financial Statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reportedfalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringProvides an entity's explanation that the preparation of financial statements in conformity with generally accepted accounting principles requires the use of management estimates. Estimates used in the determination of carrying amounts of assets or liabilities, or in disclosure of gain or loss contingencies should be disclosed if known information available prior to issuance of the financial statements indicates that both of these criteria are met: (1) It is at least reasonably possible that the estimate of the effect on the financial statements of a condition, situation, or set of circumstances that existed at the date of the financial statements will change in the near term (less than one year from the date of issuance) due to one or more future confirming events, and (2) The effect of the change would be material to the financial statements. The disclosure should indicate the nature of the uncertainty and include an indication that it is at least reasonably possible that a change in the estimate will occur in the near term. Disclosure of the factors that cause the estimate to be sensitive to change also is encouraged. Entities also may identify those areas that are subject to significant estimates.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 94-6
-Paragraph 11, 14
falsefalse20false0us-gaap_RevenueRecognitionSalesOfGoodsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery to the customer has occurred, the price is fixed or determinable and collectability is reasonably assured. Upon recognition of revenue from product sales, provisions are made for government rebates such as Medicaid reimbursements, customer incentives such as cash discounts for prompt payment, distributor fees and expected returns of expired products, as appropriate. </font></p>We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery to the customer has occurred, the price is fixedfalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's accounting policy for revenue recognition for the sale of goods, which is a transaction between an entity delivering a tangible good to a purchaser. The entity also may disclose its treatment of any unearned or deferred revenue that arises from the transaction.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
falsefalse21false0us-gaap_RevenueRecognitionRebatesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">We estimate reductions to our revenues for government-managed Medicaid programs as well as for certain other qualifying federal, state and foreign government programs based on contractual terms, historical utilization rates, new information regarding changes in these programs' regulations and guidelines that would impact the amount of the actual rebates, our expectations regarding future utilization rates for these programs and, for our U.S. product sales, channel inventory data obtained from our major U.S. wholesalers in accordance with our inventory management agreements. Government rebates that are invoiced directly to us are recorded in accrued government rebates on our Consolidated Balance Sheets. For qualified programs that can purchase our products through wholesalers at a lower contractual government price, the wholesalers charge back to us the difference between their acquisition cost and the lower contractual government price, which we record as allowances against accounts receivable. </font></p>We estimate reductions to our revenues for government-managed Medicaid programs as well as for certain other qualifying federal, state and foreign governmentfalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's accounting policy for cash rebates offered on sales.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 01-9
falsefalse22false0us-gaap_RevenueRecognitionDiscountsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">We estimate cash discounts based on contractual terms, historical utilization rates and our expectations regarding future utilization rates. </font></p>We estimate cash discounts based on contractual terms, historical utilization rates and our expectations regarding future utilization rates.falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's accounting policy for sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 01-9
falsefalse23false0gild_RevenueRecognitionDistributorFeesgildfalsenadurationRevenue recognition distributor fees.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">Under our inventory management agreements with our significant U.S. wholesalers, we pay the wholesalers a fee primarily for the compliance of certain contractually determined covenants such as the maintenance of agreed upon inventory levels. These distributor fees are based on a contractually determined fixed percentage of sales. </font></p>Under our inventory management agreements with our significant U.S. wholesalers, we pay the wholesalers a fee primarily for the compliance of certainfalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringRevenue recognition distributor fees.No authoritative reference available.falsefalse24false0us-gaap_RevenueRecognitionSalesReturnsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">We do not provide our customers with a general right of product return, but permit returns if the product is damaged or defective when received by the customer, or in the case of product sold in the Unites States and certain countries outside the United States, if the product has expired. We will accept returns for product that will expire within six months prior to or that have expired up to one year after their expiration dates. Our estimates for expected returns of expired products are based primarily on an ongoing analysis of historical return patterns. </font></p>We do not provide our customers with a general right of product return, but permit returns if the product is damaged or defective when received by thefalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's accounting policy for sales returns.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 48
-Paragraph 6, 7, 8
falsefalse25false0us-gaap_RevenueRecognitionServicesRoyaltyFeesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<div class="MetaData">
<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">Royalty revenue from sales of Lexiscan and AmBisome by Astellas US LLC and Astellas Pharma US, Inc., respectively, is recognized in the month following the month in which the corresponding sales occur. Royalty revenue from sales of our other products is generally recognized when received, which is generally in the quarter following the quarter in which the corresponding sales occur. </font></p></div>Royalty revenue from sales of Lexiscan and AmBisome by Astellas US LLC and Astellas Pharma US, Inc., respectively, is recognized in the month following thefalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's accounting policy for revenue recognition for royalty fees, which is consideration or a share of the proceeds paid by another party to the owner of a right (that is, the entity) for its use.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
falsefalse26false0us-gaap_RevenueRecognitionSalesOfServicesus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00<div class="MetaData">
<p style="margin-top: 6px; text-indent: 4%; margin-bottom: 0px;"><font style="font-family: Times New Roman;" class="_mt" size="2">Revenue from non-refundable up-front license fees and milestone payments such as under a development collaboration or an obligation to supply product, is recognized as performance occurs and our obligations are completed. In accordance with the specific terms of our obligations under these arrangements, revenue is recognized as the obligation is fulfilled or ratably over the development or manufacturing period. Revenue associated with substantive at-risk milestones is recognized based upon the achievement of the milestones as defined in the respective agreements. Advance payments received in excess of amounts earned are classified as deferred revenue on our Consolidated Balance Sheets. </font></p></div>Revenue from non-refundable up-front license fees and milestone payments such as under a development collaboration or an obligation to supply product, isfalsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalse16falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:stringItemTypestringDescribes an entity's revenue recognition policies for sales of a service. The entity also may disclose how it recognizes cost of sales for such a service transaction and its treatment of any unearned or deferred revenue that arises from the transaction.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
falsefalse1625Organization and Summary of Significant Accounting Policies (Narrative) (Details) (USD $)NoRoundingHundredThousandsNoRoundingUnKnowntruetrue
